Risk for at least one adverse event per patient · patients with chronic kidney disease (CKD) pruritus
It is very uncertain whether summary of findings table ‐ Gabapentin changes risk for at least one adverse event per patient compared with pregabalin (very low certainty).
1 finding from 1 review
Pruritus · patients with chronic kidney disease (CKD) pruritus
1 finding from 1 review
Quality of life ‐ not reported · patients with chronic kidney disease (CKD) pruritus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Patient satisfaction ‐ not reported · patients with chronic kidney disease (CKD) pruritus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mortality before hospital discharge · preterm infants with respiratory distress for initial respiratory support
It is very uncertain whether nHFV changes mortality before hospital discharge compared with invasive respiratory therapy (very low certainty).
1 finding from 1 review
Death or chronic lung disease · newborn (term* and preterm) infants with respiratory distress for initial respiratory support
nHFV showed no clear difference in death or chronic lung disease compared with nCPAP used (low certainty).
1 finding from 1 review
Intraventricular haemorrhage, Papile grade 3/4 · newborn (term* and preterm) infants with respiratory distress for initial respiratory support
nHFV showed no clear difference in intraventricular haemorrhage, Papile grade 3/4 compared with nCPAP used (low certainty).
1 finding from 1 review
Neurodevelopmental disability · newborn (term* and preterm) infants with respiratory distress for initial respiratory support
1 finding from 1 review
Mortality before hospital discharge · preterm infants with respiratory distress for initial respiratory support
nHFV showed no clear difference in mortality before hospital discharge compared with nIPPV used (low certainty).
1 finding from 1 review
Endotracheal intubation To discharge · preterm infants with respiratory distress for initial respiratory support
nHFV showed no clear difference in endotracheal intubation To discharge compared with nIPPV used (low certainty).
1 finding from 1 review
Chronic lung disease · preterm infants with respiratory distress for initial respiratory support
nHFV may leads to lower chronic lung disease compared with nIPPV used (low certainty).
1 finding from 1 review
Death or chronic lung disease · preterm infants with respiratory distress for initial respiratory support
1 finding from 1 review
Intraventricular haemorrhage, Papile grade 3/4 · preterm infants with respiratory distress for initial respiratory support
1 finding from 1 review
Neurodevelopmental disability · preterm infants with respiratory distress for initial respiratory support
1 finding from 1 review
Mortality before hospital discharge · preterm infants with respiratory distress for initial respiratory support
1 finding from 1 review
Endotracheal intubation or reintubation To discharge · preterm infants with respiratory distress for initial respiratory support
1 finding from 1 review
Endotracheal intubation or reintubation To discharge · preterm infants with respiratory distress for initial respiratory support
It is very uncertain whether nHFV changes endotracheal intubation or reintubation To discharge compared with HFNC (very low certainty).
1 finding from 1 review
Chronic lung disease · preterm infants with respiratory distress for initial respiratory support
It is very uncertain whether nHFV changes chronic lung disease compared with HFNC (very low certainty).
1 finding from 1 review
Death or chronic lung disease · preterm infants with respiratory distress for initial respiratory support
1 finding from 1 review
Intraventricular haemorrhage, Papile grade 3/4 · preterm infants with respiratory distress for initial respiratory support
1 finding from 1 review